Table 1.
Clinical characteristics of 72 patients evaluated for extratumoral gene expression subtypes
| Total | Active, N (%) | Inactive, N (%) | ||
|---|---|---|---|---|
| Menopausal Status | ||||
| Pre | 32 | 10 (31.3) | 22 (68.7) | |
| Post | 32 | 15 (46.9) | 17 (53.1) | |
| Missing | 8 | 2 (25.0) | 6 (75.0) | |
| Breast Cancer Subtype | ||||
| Normal-like | 4 | 1 (25.0) | 3 (75.0) | |
| Luminal A | 22 | 8 (36.4) | 14 (63.6) | |
| Luminal B | 9 | 3 (33.3) | 6 (66.7) | |
| Her2+ | 7 | 3 (42.9) | 4 (57.1) | |
| Basal-like | 12 | 4 (33.3) | 8 (66.7) | |
| Missing | 18 | 8 (44.4) | 10 (55.6) | |
| ER status | ||||
| Positive | 44 | 19 (43.2) | 25 (56.8) | |
| Negative | 23 | 7 (30.4) | 16 (69.6) | |
| Missing | 5 | 1 (20.0) | 4 (80.0) | |
| HER2 status | ||||
| Positive | 13 | 5 (38.5) | 8 (61.5) | |
| Negative | 38 | 12 (31.6) | 26 (68.4) | |
| Missing | 21 | 10 (47.6) | 11 (52.4) | |
| Tumor size (cm) | ||||
| 0 to 2 | 25 | 14 (56.0) | 11 (44.0) | |
| 2.1 to 4 | 24 | 9 (37.5) | 15 (62.5) | |
| 4+ | 19 | 4 (21.1) | 15 (78.9) | |
| Missing | 4 | 0 (0.0) | 4 (100) | |
| Tumor grade | ||||
| 1 | 6 | 3 (50.0) | 3 (50.0) | |
| 2 | 18 | 4 (22.2) | 14 (77.8) | |
| 3 | 28 | 13 (46.4) | 15 (53.6) | |
| Missing | 20 | 7 (35.0) | 13 (65.0) |